Cecilie Heegaard Brahe

5PUBLICATIONS
18CO-AUTHORS
Molecular targetsBiologically active moleculesRheumatology and arthritis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Oct 15, 2023
Occurrence and Prediction of Flare After Tapering of Tumor Necrosis Factor Inhibitors in Patients With Axial Spondyloarthritis.

Marie Wetterslev, Stylianos Georgiadis, Sara Nysom Christiansen

|Dec 22, 2022
Flare during tapering of biological DMARDs in patients with rheumatoid arthritis in routine care: characteristics and predictors.

L Terslev, Mikkel Ostergaard, Stylianos Georgiadis

|Oct 12, 2021
Tapering of TNF inhibitors in axial spondyloarthritis in routine care - 2-year clinical and MRI outcomes and predictors of successful tapering.

Marie Wetterslev, Stylianos Georgiadis, Inge Juul Sørensen

|Sep 20, 2020
Drug retention, inactive disease and response rates in 1860 patients with axial spondyloarthritis initiating secukinumab treatment: routine care data from 13 registries in the EuroSpA collaboration.

Brigitte Michelsen, Ulf Lindström, Catalin Codreanu

|Aug 22, 2019
Treatment response and drug retention rates in 24 195 biologic-naïve patients with axial spondyloarthritis initiating TNFi treatment: routine care data from 12 registries in the EuroSpA collaboration.

Lykke Midtbøll Ørnbjerg, Cecilie Heegaard Brahe, Johan Askling

Pageof 1

Frequent Collaborators

3 joint publications

Merete Lund Hetland

2 joint publications

Lykke Midtbøll Ørnbjerg

2 joint publications

Adrian Ciurea

2 joint publications

Mikkel Østergaard